Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-24

Clinical Trial Update: Heart Rate Control With Esmolol in Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating heart rate control with esmolol in septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esmolol (esmolol)

Snippet

Sponsor: Andrea Morelli | Conditions: Septic Shock | Phase 2 | Status: COMPLETED